| Structure | Chemical Name | CAS | MF |
|
INERTSIL HPLC COLUMN 5UM C8(3) 4.6X250
|
|
|
|
|
INERT GAS SAMPLING SYR VALVE
|
|
|
|
|
INERTSIL GUARD 5UMC4
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM PHENYL(3) 4.6X250
|
|
|
|
|
INERTSIL HPLC COLUMN 3UM ODS(3) 2.0X50
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM CN(3) 4.6X150
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM C8 4.6X50
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM ODS(2) 4X10 GD/ 3PK
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM CN(3) 4.6X250
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM C8 2.0X50
|
|
|
|
|
INERTSIL HPLC COLUMN 3UM PHENYL(3) 4.6X150
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM C4 2.0X50
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM C8(3) 4.6X150
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM C8 4X10 GD/ 3PK
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM C8 4.6X150
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM PHENYL 4X10 GD/ 3PK
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM C4 4.6X150
|
|
|
|
|
INERTSIL HPLC COLUMN 3UM C8 (3) 4.6X150
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM C4 2X10 GD/ 3PK
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM SILICA 4.6X250
|
|
|
|
|
INERTSIL HPLC COLUMN 5UM PHENYL 4.6X150
|
|
|
|
|
INERTSIL GUARD 5UM C18 (ODS)
|
|
|
|
|
INERT GAS SAMPLING VALVE (HAMILTON)
|
|
|
|
|
inert resin
|
|
|
|
|
Infiltration and anti-fouling agent for rock material
|
|
|
|
|
IMPILA
|
|
|
|
|
[125I]NERVE GROWTH FACTOR, HUMAN
|
|
|
|
|
ImPImP
|
|
|
|
|
Impinger holder
|
|
|
|
|
Impinger/Bubbler
|
|
|
|
|
Infinity resin
|
|
|
|
|
Impinem + Cilastatine
|
|
|
|
|
Impinger/Bubbler, MIDGET BUBBLER W/FRIT, 24/40 GR JT
|
|
|
|
|
IMp. J (EP): 2-Ethyl-6-Methoxynaphthalene (Ethylnerolin)
|
|
|
|
|
IMp. J (EP) as DihydrobroMide: 2-[[(5-Methyl-1H-iMidazol-4-yl)Methyl]sulphanyl]ethanaMine DihydrobroMide
|
|
|
|
|
IMp. J (EP): Methyl 3-[[(2RS)-2-BroMopropanoyl]aMino]-4-Methylthiophene-2-carboxylate (BroMo CoMpound)
|
|
|
|
|
IMp. J (EP): Methyl Benzenesulphonate
|
|
|
|
|
IMp. J (EP): 2-[2-(PropanoylaMino)-6-oxo-1,6-dihydro-9H-purin-9-yl]Methoxy] propane-1,3-diyl dipropanoate (Ganciclovir Tripropionate)
|
|
|
|
|
IMp. J (EP) as Hydrochloride: N-[3-Acetyl-4-[(2RS)-2-hydroxy-3-[(1-Methylethyl)aMino]-propoxy]phenyl]propanaMide Hydrochloride
|
|
|
|
|
IMp. J (EP): (1RS)-1,8-Diethyl-1-Methyl-1,3,4,9- tetrahydropyrano[3,4-b]indole (Decarboxy Etodolac
|
|
|
|
|
IMp. J (EP): 2-(RS)-Cyclopentyl-2-hydroxy-2-phenylacetic Acid α-CyclopentylMandelic Acid)
|
|
|
|
|
IMp. J (EP): DiphenylMethanone(Benzophenone)
|
|
|
|
|
IMp. J (EP): 16,17-[(1RS)-Butylidenebis(oxy)]-9- broMo-11,21-dihydroxypregna-1,4-diene-3,20-dione
|
|
|
|
INETERMEDIATE OF GALANTHAMINE 2
|
122584-17-2
|
C17H19NO4
|
|
INETERMEDIATE OF GALANTHAMINE 1
|
4579-60-6
|
C16H19NO3
|
|
IMPKAGLLI
|
171066-85-6
|
C45H82N10O10S
|
|
|
INGA ALBA BARK EXTRACT
|
|
|
|
|
Infiximab,RhematoidArthritis
|
|
|
|
|
IMp. K (EP): (1RS)-1-(6-Methoxynaphthalen-2-yl)ethanol
|
|
|
|
IMp. K (EP)
|
40610-41-1
|
C13H17NO3
|
|
|
IMp. K (EP): (2R)-2-[(2,2-DiMethylpropanoyl)aMino]-2-phenylacetic Acid
|
|
|
|
|
IMp. K (EP): Methyl 2-[(1RS)-1,8-Diethyl-1,3,4,9- tetrahydropyrano[3,4-b]indol-1-yl]acetate (Etodolac Methyl Ester)
|
|
|
|
|
IMp. K (EP): (2RS)-2-Cyclopentyl-2-phenyl- acetic Acid
|
|
|
|
|
IMp. K (EP): 2-Isopropoxyethyl 4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]- benzoate (Bisoprolol Ester)
|
|
|
|
|
IMp. K (EP): 8-Azaspiro[4,5]-decane-7,9-dione
|
|
|
|
|
IMp. K (EP):9-Fluoro-11b,17-dihydroxy-16b-Methyl-3,20-dioxopregna-1,4-dien-21-yl Propanoate(BetaMethasone 21- Propionate)
|
|
|
|
|
IMp. K (EP): [Oxybis(Methanetriyl)]tetrabenzene(Bis(diphenylMethyl) Ether)
|
|
|
|
|
IMp. K (EP) as Hydrochloride: N-[3-Butanoyl-4-[(2RS)-2-hydroxy-3-[(1-Methylethyl)aMino]-propoxy]phenyl]butanaMide Hydrochloride
|
|
|
|
|
IMp. K (EP): N-Methyl-1-Methylthio-2- nitroethenaMine ((EZ)-N-Methyl-1-(Methyl- sulphanyl)-2-nitroethen-1-aMine)
|
|
|
|
|
INGA EDULIS SEED EXTRACT
|
|
|
|
|
IMp. J (PharMeuropa): (2RS)-3-[4-((2-Isopropoxy-ethoxy)Methyl)phenoxy]-1,2-propanediol
|
|
|
|
|
Ingafamid
|
|
|
|
|
implantation serine proteinase, ISP2
|
|
|
|
|
IMPLANTS(GENERAL)
|
|
|
|
|
Inflammation Mediators
|
|
|
|
|
implantation serine proteinase, ISP1
|
|
|
|
|
inflammation modulatory protein, cowpox virus
|
|
|
|
|
IMp. L (EP):
|
|
|
|
|
IMp. L (EP): 1-(6-Methoxynaphthalen-2-yl)ethanone (Acetylnerolin)
|
|
|
|
|
IMp. L (EP): (2R)-2-AMino-2-phenylacetic Acid (D-Phenylglycine)
|
|
|
|
|
IMp. L (EP): 1-(4-Fluorophenyl)ethanone
|
|
|
|
|
IMp. L (EP): 13-Ethyl-17-hydroxy-18,19-dinor-17a-pregna-5,15-dien-20-yn-3-one(D5(6)-Gestodene)
|
|
|
|
|
IMp. L (EP) as Hydrochloride: 4-[[(2RS)-2-Hydroxy-3-(isopropylaMino)propyl]oxy]benzaldehyde Hydrochloride(4-[(2RS)-2-Hydroxy-3-[(1-Methylethyl)aMino]propoxy]- benzaldehyde Hydrochloride)
|
|
|
|
|
IMp. L (EP): 8-(4-Chlorobutyl)-8-azaspiro[4.5]-decane-7,9-dione
|
|
|
|
|
IMp. L (EP): 1-Methylethyl 4-Hydroxy-2-Methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide
|
|
|
|
|
IMp. L (EP): 5-(2-Chlorobenzyl)-6,7-dihydrothieno[3,2-c]pyridin-4(5H)-one
|
|
|
|
impletol depot Bayer
|
95017-34-8
|
C27H39N7O5
|
|
Impletol
|
8013-38-5
|
C13H20N2O2.C8H10N4O2.ClH
|
|
|
[125I]-NEUROPEPTIDE S (RAT)
|
|
|
|
|
[125I]-NEUROPEPTIDE S (HUMAN)
|
|
|
|
IMPLITAPIDE
|
177276-67-4
|
C35H37N3O2
|
|
|
Infliximab
|
170277-31-3
|
|
|
|
Infliximab
|
|
|
|
|
IMp. M (EP): 2-Methoxynaphthalene (Nerolin)
|
|
|
|
|
IMp. M (EP): 8-(4-BroMobutyl)-8-azaspiro[4.5]-decane-7,9-dione
|
|
|
|
|
IMp. M (EP): CyclopentylphenylMethanone
|
|
|
|
|
Influenza A M2 coat protein (22 - 46)
|
|
|
|
|
InfluVictoria
|
|
|
|
|
InfluenzaB(Nucleoprotein)
|
|
|
|
|
INFLUENZAAHAEMAGGLUTININH5,MABANTI-
|
|
|
|
|
INFLUENZATYPEA,H1N1,CLONE:58AB7-19-18,MABANTI-:IF
|
|
|
|
|
INFLUENZATYPEA,H1N1,CLONE:58CE8-1-5,MABANTI-
|
|
|
|
|
Influenza A Antigen ELISA
|
|
|
|
|
INFLUENZATYPEB,MIE/1/93,RABBITANTI-
|
|
|
|
|
Influenza A IgA ELISA
|
|
|
|
|
INFLUENZABVIRUS,B/VICTORIA/504/00
|
|
|
|
|
INFLUENZA A (H3N2)
|
|
|
|
|
INFLUENZABVIRUS,TOKIO53/99
|
|
|
|
|
influenza virus membrane protein (58-66)
|
|
|
|
|
influenza A virus nucleoprotein
|
|
|